Intellia Therapeutics NTLA Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Intellia Therapeutics's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Intellia Therapeutics's total current liabilities?
- Intellia Therapeutics (NTLA) reported total current liabilities of $76.45M in Q1 2026.
- How has Intellia Therapeutics's total current liabilities changed year-over-year?
- Intellia Therapeutics's total current liabilities decreased by 32.1% year-over-year, from $112.59M to $76.45M.
- What is the long-term trend for Intellia Therapeutics's total current liabilities?
- Over 5 years (2020 to 2025), Intellia Therapeutics's total current liabilities has grown at a 10.1% compound annual growth rate (CAGR), from $64.25M to $103.88M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.